Fig. 1From: Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effectsKaplan Meier analysis of survival in patients with reduced and full dosage of standard chemotherapy back bone (FOLFIRI, FOLFOX). Survival analysis showed no difference in survival (p = 0.430, Log Rank)Back to article page